S&P 500   3,116.80 (-0.11%)
DOW   27,853.18 (-0.29%)
QQQ   203.13 (-0.12%)
BABA   182.95 (-1.24%)
GE   11.47 (-0.35%)
T   36.83 (-3.08%)
ACB   2.63 (+12.39%)
F   8.80 (-1.24%)
PRI   132.32 (+0.52%)
BAC   32.83 (-0.33%)
DIS   147.82 (-0.38%)
S&P 500   3,116.80 (-0.11%)
DOW   27,853.18 (-0.29%)
QQQ   203.13 (-0.12%)
BABA   182.95 (-1.24%)
GE   11.47 (-0.35%)
T   36.83 (-3.08%)
ACB   2.63 (+12.39%)
F   8.80 (-1.24%)
PRI   132.32 (+0.52%)
BAC   32.83 (-0.33%)
DIS   147.82 (-0.38%)
S&P 500   3,116.80 (-0.11%)
DOW   27,853.18 (-0.29%)
QQQ   203.13 (-0.12%)
BABA   182.95 (-1.24%)
GE   11.47 (-0.35%)
T   36.83 (-3.08%)
ACB   2.63 (+12.39%)
F   8.80 (-1.24%)
PRI   132.32 (+0.52%)
BAC   32.83 (-0.33%)
DIS   147.82 (-0.38%)
S&P 500   3,116.80 (-0.11%)
DOW   27,853.18 (-0.29%)
QQQ   203.13 (-0.12%)
BABA   182.95 (-1.24%)
GE   11.47 (-0.35%)
T   36.83 (-3.08%)
ACB   2.63 (+12.39%)
F   8.80 (-1.24%)
PRI   132.32 (+0.52%)
BAC   32.83 (-0.33%)
DIS   147.82 (-0.38%)
Log in

Sinopharm Stock Price, Forecast & Analysis (OTCMKTS:SHTDF)

$3.54
-0.09 (-2.37 %)
(As of 11/11/2019)
Today's Range
$3.54
Now: $3.54
$3.54
50-Day Range
$3.08
MA: $3.35
$3.62
52-Week Range
$3.08
Now: $3.54
$5.04
Volume1,000 shs
Average Volume3,179 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medical devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2018, this segment had 5,183 retail pharmacies. Its Medical Devices segment distributes medical devices. Its Other Business segment engages in the production, sale, and financial leasing of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.

Industry, Sector and Symbol

Industry Medical Distributors
Sub-IndustryN/A
SectorDistribution Services
Current SymbolOTCMKTS:SHTDF
CUSIPN/A
CIKN/A
Phone86 21 2305 2666

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees69,722
Next Earnings DateN/A
OptionableNot Optionable

Receive SHTDF News and Ratings via Email

Sign-up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter.


Sinopharm (OTCMKTS:SHTDF) Frequently Asked Questions

What is Sinopharm's stock symbol?

Sinopharm trades on the OTCMKTS under the ticker symbol "SHTDF."

Has Sinopharm been receiving favorable news coverage?

Media stories about SHTDF stock have been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sinopharm earned a news impact score of -1.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the near term. View News Stories for Sinopharm.

Who are some of Sinopharm's key competitors?

Who are Sinopharm's key executives?

Sinopharm's management team includes the folowing people:
  • Mr. Zhiming Li, Chairman (Age 56)
  • Mr. Yong Liu, Pres & Exec. Director (Age 50)
  • Mr. Yijian Wu, Company Sec. (Age 49)
  • Mr. Wanyong Lian, VP (Age 48)
  • Mr. Dongjiu Li, VP (Age 54)

How do I buy shares of Sinopharm?

Shares of SHTDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sinopharm's stock price today?

One share of SHTDF stock can currently be purchased for approximately $3.54.

What is Sinopharm's official website?

The official website for Sinopharm is http://ir.sinopharmgroup.com.cn/.

How can I contact Sinopharm?

The company can be reached via phone at 86 21 2305 2666.


MarketBeat Community Rating for Sinopharm (OTCMKTS SHTDF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Sinopharm and other stocks. Vote "Outperform" if you believe SHTDF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHTDF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel